Developed in collaboration with REPROCELL, CELLvo ™ Atrial Cardiomyocyte delivers non-genetically modified human heart cells that are chamber specific and derived from iPS (stem) cells SAN ANTONIO, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback